Wyeth Pharmaceuticals, citing data from IMS Health, reported last month that its dual-action antidepressant Effexor XR (venlafaxine HCl) has become the fastest-growing therapy option in the antidepressant market. That market is valued at $13 billion annually. In addition to depression, Effexor XR, a serotonin/norepinephrine reuptake inhibitor is indicated for the treatment of generalized anxiety disorder. It is thought to work by increasing the levels in the brain of serotonin and norepinephrine.
COPYRIGHT 2002 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2002 Gale Group
Drug Store News
Subscribe to:
Post Comments (Atom)
1 comment:
Effexor doesnt have any other effect if I Buy Generic Viagra and use it almost all days ?
Post a Comment